1. Home
  2. TTGT vs LXRX Comparison

TTGT vs LXRX Comparison

Compare TTGT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechTarget Inc.

TTGT

TechTarget Inc.

N/A

Current Price

$3.84

Market Cap

245.8M

ML Signal

N/A

LXRX

Lexicon Pharmaceuticals Inc.

N/A

Current Price

$2.04

Market Cap

996.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTGT
LXRX
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.8M
996.7M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
TTGT
LXRX
Price
$3.84
$2.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$10.75
$4.15
AVG Volume (30 Days)
221.4K
2.2M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$4.45
N/A
Revenue Next Year
$2.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$3.37
$1.06
52 Week High
$7.15
$2.68

Technical Indicators

Market Signals
Indicator
TTGT
LXRX
Relative Strength Index (RSI) 49.25 36.00
Support Level $3.65 $1.50
Resistance Level $4.11 $2.49
Average True Range (ATR) 0.17 0.08
MACD 0.00 -0.03
Stochastic Oscillator 50.00 26.95

Price Performance

Historical Comparison
TTGT
LXRX

About TTGT TechTarget Inc.

TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: